助手标题
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
共[5]页 共[98]条 当前为第1条到20条
 

相关语句
transitional cell carcinoma of the bladder
Prostatic adenocarcinoma coexist with transitional cell carcinoma of the bladder and prostate - A case report and review of the
      
Transitional cell carcinoma of the bladder: New approaches to the treatment of advanced disease
      
Combined chemotherapy and external beam radiotherapy for transitional cell carcinoma of the bladder
      
A growing body of evidence supports the treatment of invasive transitional cell carcinoma of the bladder with transurethral resection, chemotherapy, and external beam radiotherapy.
      
Adjuvant chemotherapy for transitional cell carcinoma of the bladder: Paradigms for the design of clinical trials
      
The role of regional lymph node dissection (LND) in surgical management of high-grade, invasive transitional cell carcinoma of the bladder has evolved over the past several decades.
      
Which patients with transitional cell carcinoma of the bladder or prostatic urethra are candidates for an orthotopic neobladder
      
In urology, hematoporphyrin derivative (HpD) and Photofrin (Axcan Scandipharm Inc., Birmingham, AL) are used most commonly as photosensitizing agents predominantly for the treatment of transitional cell carcinoma of the bladder.
      
Growth factors and their receptors are significant to the biology of transitional cell carcinoma of the bladder.
      
Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder
      
The purpose of this study was the evaluation of neo-adjuvant M-VAC chemotherapy and bladder preservation in patients with locally advanced transitional cell carcinoma of the bladder.
      
Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder
      
Evaluation of the immunocompetence of patients with transitional cell carcinoma of the bladder
      
The antigenicity of transitional cell carcinoma of the bladder has stimulated the search for effective immunotherapeutic agents in the treatment of this disease.
      
Since January 1978 we performed chemoimmune prophylaxis in 130 patients with superficial transitional cell carcinoma of the bladder.
      
The expression of transferrin receptors (TFR) by normal and neoplastic urothelial cells was studied in "control" patients and in patients with transitional cell carcinoma of the bladder.
      
This paper represents the first report of a codon 59 mutation in Ki-ras from a spontaneous human transitional cell carcinoma of the bladder.
      
Mutations in codons 12, 13 and 61 have been reported in a wide variety of human cancers, including transitional cell carcinoma of the bladder.
      
In the KK-47 grafts derived from a transitional cell carcinoma of the bladder, the use of CY alone and the combination of CY and hyperthermia produced a significant tumour regression rate.
      
Transitional cell carcinoma of the bladder has a high recurrence rate after local treatment.
      
 

首页上一页12345下一页尾页 

 
CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社